A
HAE icon

AlphaQuest’s Haemonetics HAE Stock Holding History

AlphaQuest’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,620
Closed -$210K – 866
2025
Q4 		$210K Sell
2,620
-4,090
-61% -$275K 0.01% 1421
2025
Q3 		$327K Buy
6,710
+2,073
+45% +$128K 0.02% 1100
2025
Q2 		$346K Buy
4,637
+1,497
+48% +$99.1K 0.03% 804
2025
Q1 		$200K Buy
3,140
+1,309
+71% +$89K 0.02% 998
2024
Q4 		$143K Buy
1,831
+1,826
+36,520% +$147K 0.02% 989
2024
Q3 		$402 Sell
5
-1,140
-100% -$92.1K ﹤0.01% 1753
2024
Q2 		$94.7K Sell
1,145
-2,160
-65% -$190K 0.01% 936
2024
Q1 		$282K Sell
3,305
-641
-16% -$50.3K 0.05% 539
2023
Q4 		$337K Buy
+3,946
New +$341K 0.07% 484

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AlphaQuest's HAE Position: Q1 2026 in Review

AlphaQuest sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 2,620 shares — an estimated $210K sold.

AlphaQuest first reported a position in HAE in Q4 2023 and held it in 9 quarters. The position peaked at $346K in Q2 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • AlphaQuest reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 2,620 Haemonetics shares in Q1 2026, an estimated $210K.
  • AlphaQuest first reported a position in Haemonetics in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Haemonetics position peaked at $346K in Q2 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.